Stock listing

OTC:IOTCF Innovotech Inc. Stock

US listing (OTC) of Innovotech Inc. · home listing TSXV:IOT

Follow Innovotech Inc. into a list and get an email when it puts out news.

Home listing price · TSXV:IOT

$0.07 CAD 0.00 (0.0%)

Close on Nov 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:IOT

Past year -68.2% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.07 – $0.07 CADNov 19, 2026
Volume
16,000 sharesNov 19, 2026
Market cap
$3.81M CADAt the close on Nov 19, 2026 · price × 54.44M shares outstanding
52-week range
$0.06 – $0.29 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$1,995 CADMedian day 0 shares · 38 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Innovotech Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:IOT · Home$0.07 CAD0.00 (0.0%)16,000$0.07$0.07$0.07$0.07Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:IOT · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.070.000.0%$0.07$0.07$0.0716,000
$0.07+0.005+7.7%$0.07$0.07$0.06587,400
$0.065-0.025-27.8%$0.09$0.09$0.065326,055
$0.090.000.0%$0.09$0.09$0.090
$0.09+0.01+12.5%$0.08$0.09$0.07212,700
$0.080.000.0%$0.08$0.08$0.0830,000
$0.08+0.02+33.3%$0.07$0.08$0.07163,000
$0.060.000.0%$0.06$0.06$0.060
$0.060.000.0%$0.06$0.06$0.060
$0.060.000.0%$0.06$0.06$0.060
$0.06-0.01-14.3%$0.06$0.06$0.0610,000
$0.070.000.0%$0.07$0.07$0.0797,100
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.071,700
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.074,500
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.074,000
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.07124,900
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.07166,300
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.07-0.01-12.5%$0.07$0.07$0.0735,500
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.0825,000
$0.08+0.01+14.3%$0.08$0.08$0.0855,000
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.08$0.08$0.079,000
$0.07-0.01-12.5%$0.08$0.08$0.0726,400
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.0816,000
$0.080.000.0%$0.08$0.08$0.089,000
$0.080.000.0%$0.08$0.08$0.0850,000
$0.080.000.0%$0.08$0.08$0.080
$0.08-0.01-11.1%$0.08$0.08$0.081,000
$0.09+0.01+12.5%$0.09$0.09$0.0910,000
$0.080.000.0%$0.08$0.08$0.080
$0.080.000.0%$0.08$0.08$0.084,000
$0.080.000.0%$0.08$0.08$0.0855,000
$0.080.000.0%$0.08$0.08$0.080
$0.08+0.01+14.3%$0.08$0.08$0.082,000
$0.07-0.01-12.5%$0.08$0.08$0.07213,000
Ticker
OTC:IOTCF
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Innovotech Inc. news

Innovotech Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 92 in all · newest Nov 10, 2026 · oldest 2017
Decks
6 decks · latest May 2025

Where Innovotech Inc. is listed

ListingExchangeCountryCurrency
TSXV:IOT · Home listingTSXVCanadaCAD
OTC:IOTCF · This pageOTCUnited StatesUSD
Cboe Canada:IOTCboe CanadaCanadaCAD

Valuation

EV/sales 1.0× against a median of 4.5×: 3rd lowest of 8 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026

Enterprise value
$3.60M CAD
P/E
Loss
EV/sales
1.0×
EV/EBITDA
Negative EBITDA
Price/book
1.5×
Gross margin
39.4%
Operating margin
−21.4%
Net margin
−21.1%
Debt to equity
0.1×
Beta vs S&P/TSX Composite
0.39

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Innovotech Inc. · TSXV:IOTUS$2.66MUS$2.51Mn/a1.0×n/a1.5×−21.1%0.1×0.39
SDS Optic Spolka Akcyjna · NEWCONNECT:SDSUS$3.82MUS$3.57Mn/a13.7×n/a11.8×−269.4%0.0×n/a
genXone SA · NEWCONNECT:GX1US$3.47MUS$2.77Mn/a4.5×18.6×1.9×−67.9%0.0×n/a
Telo Genomics Corp. · TSXV:TELOUS$2.80MUS$2.12Mn/an/an/an/an/an/a0.04
Advanced Biomed Inc. · NASDAQ:ADVBUS$2.73MUS$3.12M0.5×12.2×n/a0.2×n/a0.1×0.35
Qlife Holding AB · OMXSTO:QLIFEUS$2.49MUS$2.88Mn/a34.1×n/a9.6×n/a3.1×n/a
Physiomics PLC · LSE:PYCUS$2.46MUS$1.91Mn/a1.6×n/a3.6×−74.1%0.0×n/a
20/20 BioLabs, Inc. · NASDAQ:AIDXUS$2.10M−US$1.01Mn/a−0.5×n/a3.4×−317.8%0.9×1.41
Bluejay Diagnostics, Inc. · NASDAQ:BJDXUS$1.90M−US$5.43Mn/an/an/a0.3×n/a0.0×1.71
Accustem Sciences Inc · OTC:ACUTUS$1.90MUS$1.88Mn/an/an/an/an/an/a0.19
InVitro International · OTC:IVROUS$1.87MUS$644,26029.6×0.8×14.0×1.1×8.2%0.0×0.17
Median of the othersUS$2.47MUS$2.02M15.1×4.5×16.3×2.6×−74.1%0.0×0.27

Team and board

Officers

OfficerRole
Craig MilneCEO, President, Director
Craig KalvinChief Financial Officer
Jodi McDonaldChief Operating Officer
Greg YoungVP Corporate Services
Rod SzarkaChief Commercial Officer

Board

DirectorRole
James TimourianDirector, Board Chair
Arden TseDirector
Brad ClarkDirector
Craig MilneCEO, President, Director
David TamDirector
Julie WrightDirector
Karen FarkasDirector

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 9, 2026 · After close0.0%
Q2 2023Aug 15, 2023 · After close−12.5%
Q1 2023May 23, 2023 · After close0.0%
Q3 2021Nov 16, 2021−9.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2025)Investor deck18 slidesMay 2025
Investor Presentation (May 2022)Investor deck16 slidesMay 2022
Investor Presentation (June 2021)Investor deck16 slidesJune 2021
Investor Presentation (April 2021)Investor deck15 slidesApril 2021
Investor Presentation (December 2020)Investor deck16 slidesDecember 2020
Fact Sheet (June 2018)Fact sheet2 slidesJune 2018

Open Decks

Financings

RaiseDateIn US dollars
Unsecured convertible debenture
Announced: up to C$200,000
Insiders: A related party is expected to be the single participant in the Offering
Use of proceeds: Expand analytical services through Keystone Labs, including lab equipment for hazardous drug testing and further analytical capabilities
Oct 16, 2025US$142,369
Warrant exercise of share purchase warrants
Announced: C$65,385 · Warrants at C$0.17
Insiders: A related party intends to exercise the warrants
Oct 16, 2025US$46,544

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CAD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.53M2.19M1.18M1.13M1.48M1.19M986.2K826.9K990.3K1.01M
Cost of revenue2.14M1.08M700.8K346.3K363.2K326.5K291.1K220.6K290.6K272.3K
Gross profit2.40M1.11M481.8K779.5K1.12M866.9K695.1K606.3K699.8K733.3K
Research and development523.2K276.7K216.5K111.0K34.9K48.0K23.4K39.1K67.5K148.6K
Selling, general and administrative2.27M1.01M686.4K832.5K815.8K760.5K718.2K697.5K608.0K498.6K
Operating income23.9K48.1K-379.7K-140.4K268.0K99.3K-19.9K-127.0K36.0K86.1K
Depreciation and amortization142.8K61.6K78.3K114.2K70.9K17.9K13.3K15.4K16.8K19.4K
EBITDA166.8K109.8K-301.4K-26.3K338.8K117.3K-6.60K-111.6K52.8K105.5K
Interest expense33.0K9.96K5575.02K4.38K3.00K6.00K65000
Income before tax88.6K214.8K-157.6K-136.5K367.1K106.3K-48.8K-127.6K753.4K-215.5K
Income tax00
Net income94.4K224.7K-157.6K-136.5K367.1K106.3K-48.8K-127.6K753.4K-215.5K
Earnings per share, basic0.000.00-0.00-0.000.010.00-0.00-0.000.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.62M725.4K160.5K469.1K422.4K530.1K96.7K28.8K324.5K33.2K
Short-term investments068.1K81.6K72.2K20.0K
Receivables507.6K536.1K204.3K184.9K358.3K136.9K101.2K147.8K87.8K176.3K
Inventory185.5K128.4K70.0K42.2K59.8K38.9K21.5K28.1K38.7K36.3K
Current assets3.02M1.68M565.1K826.0K993.5K752.7K224.8K211.4K459.0K252.9K
Property, plant and equipment229.4K69.7K50.1K60.9K68.3K72.4K
Total assets4.43M3.22M1.22M1.22M1.43M822.4K274.9K272.3K527.3K325.3K
Accounts payable376.3K286.9K104.2K83.7K73.3K65.3K217.9K498.1K
Current liabilities522.1K421.0K175.5K165.3K219.0K157.5K76.8K178.9K345.8K1.54M
Long-term debt160.5K20.0K100.0K
Total liabilities784.7K596.8K217.9K165.3K256.0K177.5K176.8K178.9K345.8K1.54M
Shareholders' equity3.60M2.57M930.6K1.06M1.18M645.0K98.1K93.5K181.5K-1.22M
Shares outstanding54.4M49.7M39.0M38.9M38.9M38.3M36.2M36.2M33.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-62.4K-81.6K-228.1K208.4K25.0K175.2K76.3K-280.7K-158.7K2.32K
Capital spending-471.5K-202.3K-42.9K-71.5K-60.1K-37.7K-2.44K-9.32K-13.7K-13.7K
Free cash flow-533.9K-283.9K-271.0K136.9K-35.1K137.6K73.9K-290.1K-172.4K-11.3K
Cash from investing-60.1K-37.7K-2.44K-9.32K-11.6K4.00K
Cash from financing878.0K1.14M-37.6K-90.2K-72.6K305.9K-6.00K-5.65K461.6K-5.59K
Dividends paid000000000
Share buybacks528.0K528.0K
Change in cash894.2K564.9K-308.5K46.6K-107.7K433.5K67.9K-295.7K291.4K726

Open Financials

Cap table

Built by 6ix from Innovotech Inc.’s releases · as of Oct 16, 2025

Common shares
54,438,235
Fully diluted
54,438,235

Fully diluted

LineShares
Common shares54,438,235

Share count over time

CountShares
Nov 22, 202654,438,235

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy5,000CAD 0.07CAD 350Nov 17, 2026
Jodi McDonald
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Buy14,666CAD 0.07CAD 1,100Nov 13, 2026
Craig Milne
Director of Issuer
Buy20,000CAD 0.08CAD 1,600Nov 13, 2026
David Shong-Tak Tam
Director of Issuer
Buy108,000CAD 0.07CAD 8,100Nov 13, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy10,000CAD 0.08CAD 800Nov 12, 2026
David Shong-Tak Tam
Director of Issuer
Buy180,000CAD 0.07CAD 12,600Nov 11, 2026
Bradley Alan Clark
Director of Issuer
Buy900CAD 0.07CAD 59Sep 24, 2026
Bradley Alan Clark
Director of Issuer
Buy50,000CAD 0.08CAD 4,000Sep 1, 2026
David Shong-Tak Tam
Director of Issuer
Buy90,000CAD 0.08CAD 7,200Aug 24, 2026
Bradley Alan Clark
Director of Issuer
Buy2,000CAD 0.07CAD 150Aug 20, 2026
All 46 trades
TradeTradeSharesPriceValueDate
Craig Milne
Director of Issuer
Buy92,000CAD 0.07CAD 6,440Aug 19, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy10,000CAD 0.09CAD 850Aug 14, 2026
Bradley Alan Clark
Director of Issuer
Buy2,000CAD 0.07CAD 150Aug 5, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy20,000CAD 0.08CAD 1,600Aug 4, 2026
Jodi McDonald
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Buy5,000CAD 0.10CAD 500Jul 20, 2026
Craig Milne
Director of Issuer
Buy10,000CAD 0.09CAD 900Jul 7, 2026
Craig Milne
Director of Issuer
Buy135,000CAD 0.08CAD 10,800Jul 3, 2026
Bradley Alan Clark
Director of Issuer
Buy37,500CAD 0.08CAD 3,000Jul 2, 2026
Julienne Wright
Director of Issuer
Buy10,000CAD 0.13CAD 1,300Jun 24, 2026
David Shong-Tak Tam
Director of Issuer
Buy66,000CAD 0.10CAD 6,930Jun 17, 2026
Bradley Alan Clark
Director of Issuer
Buy19,500CAD 0.11CAD 2,145Jun 5, 2026
Bradley Alan Clark
Director of Issuer
Buy5,500CAD 0.11CAD 605Jun 3, 2026
Craig Milne
Director of Issuer
Buy80,000CAD 0.12CAD 9,200May 15, 2026
David Shong-Tak Tam
Director of Issuer
Buy111,000CAD 0.13CAD 14,430May 15, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy50,000CAD 0.13CAD 6,250May 14, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Buy50,000CAD 0.13CAD 6,500May 14, 2026
Bradley Alan Clark
Director of Issuer
Buy3,600CAD 0.12CAD 432May 13, 2026
David Shong-Tak Tam
Director of Issuer
Buy111,000CAD 0.14CAD 14,985May 13, 2026
Bradley Alan Clark
Director of Issuer
Buy8,800CAD 0.14CAD 1,232May 13, 2026
Bradley Alan Clark
Director of Issuer
Buy1,000CAD 0.19CAD 190Apr 17, 2026
David Shong-Tak Tam
Director of Issuer
Buy24,500CAD 0.17CAD 4,288Apr 8, 2026
David Shong-Tak Tam
Director of Issuer
Buy33,000CAD 0.18CAD 5,940Apr 1, 2026
David Shong-Tak Tam
Director of Issuer
Buy80,000CAD 0.17CAD 14,000Apr 1, 2026
Alan Clyde Hayes Savage
10% Security Holder of Issuer
Other800,000CAD 0.10CAD 80,000Feb 12, 2026
Craig Milne
Director of Issuer
Option exercise800,000CAD 0.10CAD 80,000Feb 11, 2026
James Gregory Timourian
Senior Officer of Issuer
Sale19,500CAD 0.25CAD 4,875Feb 9, 2026
James Gregory Timourian
Senior Officer of Issuer
Sale3,000CAD 0.25CAD 750Feb 5, 2026
James Gregory Timourian
Senior Officer of Issuer
Sale1,500CAD 0.26CAD 390Jan 19, 2026
James Gregory Timourian
Senior Officer of Issuer
Sale16,000CAD 0.26CAD 4,160Jan 8, 2026
James Gregory Timourian
Senior Officer of Issuer
Sale22,000CAD 0.25CAD 5,500Dec 10, 2025
Bradley Alan Clark
Director of Issuer
Buy4,047CAD 0.21CAD 850Dec 5, 2025
James Gregory Timourian
Senior Officer of Issuer
Sale20,000CAD 0.21CAD 4,200Dec 5, 2025
James Gregory Timourian
Senior Officer of Issuer
Gift125,000CAD 0.23CAD 28,750Dec 4, 2025
James Gregory Timourian
Senior Officer of Issuer
Sale8,000CAD 0.21CAD 1,680Dec 3, 2025
Arden Tse
Director of Issuer
Buy25,000CAD 0.21CAD 5,250Dec 3, 2025
Arden Tse
Director of Issuer
Buy21,000CAD 0.22CAD 4,620Nov 24, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Arden TseDirector · Since at least Jun 16, 2026
Brad ClarkDirector · Since at least Jun 16, 2026
Craig KalvinChief Financial Officer · Since at least Jun 16, 2026
Craig MilneCEO, President, Director · Since at least Oct 29, 2026
David TamDirector · Since at least Jun 16, 2026
Greg YoungVP Corporate Services · Since at least Jun 24, 2026
James TimourianDirector, Board Chair · Since at least Jun 16, 2026
Jodi McDonaldChief Operating Officer · Since at least Feb 5, 2026
Julie WrightDirector · Since at least Jun 16, 2026
Karen FarkasDirector · Since at least Jun 16, 2026
All 12 people
PersonSeat
Patricia NadwornyChief Scientific Officer · May 8, 2025 – Nov 4, 2026 · Past
Rod SzarkaChief Commercial Officer · Since at least Feb 5, 2026

Open People

Log in to ask 6ix AI your own questions about Innovotech Inc.